You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 30, 2025

SODIUM CHLORIDE 5% IN PLASTIC CONTAINER Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Sodium Chloride 5% In Plastic Container patents expire, and when can generic versions of Sodium Chloride 5% In Plastic Container launch?

Sodium Chloride 5% In Plastic Container is a drug marketed by B Braun and Baxter Hlthcare and is included in two NDAs.

The generic ingredient in SODIUM CHLORIDE 5% IN PLASTIC CONTAINER is sodium chloride. There are one thousand four hundred and seventy-two drug master file entries for this compound. Twenty-seven suppliers are listed for this compound. Additional details are available on the sodium chloride profile page.

AI Deep Research
Questions you can ask:
  • What is the 5 year forecast for SODIUM CHLORIDE 5% IN PLASTIC CONTAINER?
  • What are the global sales for SODIUM CHLORIDE 5% IN PLASTIC CONTAINER?
  • What is Average Wholesale Price for SODIUM CHLORIDE 5% IN PLASTIC CONTAINER?
Summary for SODIUM CHLORIDE 5% IN PLASTIC CONTAINER
Drug patent expirations by year for SODIUM CHLORIDE 5% IN PLASTIC CONTAINER
Pharmacology for SODIUM CHLORIDE 5% IN PLASTIC CONTAINER

US Patents and Regulatory Information for SODIUM CHLORIDE 5% IN PLASTIC CONTAINER

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
B Braun SODIUM CHLORIDE 5% IN PLASTIC CONTAINER sodium chloride INJECTABLE;INJECTION 019635-004 Mar 9, 1988 AP RX No No ⤷  Get Started Free ⤷  Get Started Free ⤷  Get Started Free
Baxter Hlthcare SODIUM CHLORIDE 5% IN PLASTIC CONTAINER sodium chloride INJECTABLE;INJECTION 019022-002 Nov 1, 1983 AP RX Yes No ⤷  Get Started Free ⤷  Get Started Free ⤷  Get Started Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Market Dynamics and Financial Trajectory for Sodium Chloride 5% in Plastic Container

Last updated: August 18, 2025

Introduction

Sodium chloride 5% in plastic containers, commonly known as normal saline, is a fundamental pharmaceutical solution used extensively across healthcare sectors. It serves as an intravenous (IV) fluid for hydration, electrolyte management, and drug delivery. This analysis explores the evolving market dynamics, key drivers, challenges, and economic forecasts shaping its financial trajectory. The report aims to empower stakeholders to navigate this landscape with data-driven insights.

Market Overview

The global saline solution market, primarily comprising sodium chloride 5% in plastic bottles, is projected to grow at a compound annual growth rate (CAGR) of approximately 6-8% over the next five years. Factors driving this expansion include healthcare infrastructure development, rising prevalence of chronic diseases requiring IV therapy, and increasing hospital admissions across emerging and developed economies.

Market segmentation primarily includes:

  • Application sectors: Hospitals, outpatient clinics, long-term care facilities, and home healthcare.
  • End users: Pharmaceutical manufacturing, healthcare providers, and consumers.
  • Geographical regions: North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa.

Market Drivers

Growing Healthcare Infrastructure and Hospitalization Rates

The global increase in hospital capacity, coupled with an aging population, has amplified demand for sterile IV fluids. Notably, North America and Europe possess mature markets where sodium chloride 5% is a standard requirement in hospitals and clinics.

Rising Prevalence of Chronic Diseases and Emergency Care

Chronic conditions such as diabetes, renal failure, and gastrointestinal disorders require consistent hydration therapy, augmenting sodium chloride solution consumption. Additionally, the COVID-19 pandemic prompted an increased reliance on IV therapy in critical care, temporarily boosting demand.

Expansion of Home Healthcare and Emergency Medical Services

The shift toward outpatient and home administration of IV therapy, especially accelerated during the pandemic, has expanded the market for pre-packaged sterile solutions in plastic containers, offering convenience and safety.

Regulatory Approvals and Quality Standards

Stringent regulatory requirements by agencies like the FDA and EMA necessitate high-quality manufacturing, which, while challenging, can open opportunities for market entrants capable of compliance.

Innovation in Packaging and Delivery Systems

Advancements such as pre-filled, ready-to-use plastic containers with improved stability, safety features, and compatibility with infusion devices attract consumers and healthcare providers.

Market Challenges

Price Competition and Cost Sensitivity

Intense competition among manufacturers leads to pricing pressures, especially in commoditized products like saline solutions. Public healthcare systems and insurers often drive cost containment measures, impacting profit margins.

Regulatory and Quality Compliance

Meeting global quality standards involves significant investments in manufacturing facilities, quality monitoring, and validation processes, acting as barriers for entry or expansion in certain markets.

Supply Chain Disruptions

Global supply chain issues, including raw material shortages and logistical bottlenecks, have periodically hampered production and distribution, especially during the COVID-19 crisis.

Environmental Concerns

Environmental impact of plastic waste from single-use containers is increasingly scrutinized, prompting calls for sustainable packaging solutions, which may entail additional costs.

Financial Trajectory and Revenue Projections

Based on current market trends, the revenue generated from sodium chloride 5% solutions in plastic containers is expected to reach USD 2.5-3.0 billion globally by 2027. North America remains the leading market, accounting for approximately 40% of revenues, due to high healthcare spending and widespread adoption.

Emerging markets in Asia-Pacific are experiencing rapid growth, driven by expanding healthcare infrastructure, urbanization, and increased healthcare access. China and India collectively represent over 20% of global demand, with forecasts indicating double-digit growth in these regions.

Profit margins are influenced heavily by manufacturing scale, regulatory compliance costs, and competitive pricing. Large multinational firms often benefit from economies of scale, while regional players focus on cost-efficient manufacturing and localization to sustain margins.

Competitive Landscape

Leading global manufacturers include Baxter International, B. Braun Melsungen AG, Hospira (a Pfizer company), and Fresenius Kabi. These companies focus on product standardization, robust supply chains, and compliance with international standards to maintain market share.

Emerging players are investing in innovations such as pre-filled, single-use containers and environmentally sustainable packaging to differentiate offerings.

Regulatory and Policy Impact

Regulatory frameworks significantly influence market entry and operation. Continuous updates, especially concerning environmental policies, quality standards, and labeling regulations, necessitate adaptive strategies. The global trend toward stricter quality controls can increase operational costs but also provides opportunities for trusted brands.

Future Innovation and Market Trends

Sustainable Packaging

The push toward environmentally friendly solutions will likely reshape packaging practices. Biodegradable or recyclable materials for plastic containers could become industry standards, albeit at a higher initial cost.

Automation and Digital Monitoring

Integration of smart infusion devices and IoT-enabled monitoring reduces medication errors and enhances patient safety. These innovations may increase initial costs but offer long-term savings and improved market acceptance.

Customization and Specialty Solutions

Development of tailored formulations—such as sterile isotonic solutions with specific additives—may open niche markets and command premium pricing.

Expansion into Developing Markets

As healthcare infrastructure advances, lower-cost manufacturing and distribution channels will facilitate increased penetration into Africa, Southeast Asia, and Latin America.

Conclusion: Strategic Insights

The sodium chloride 5% in plastic container market is positioned for steady growth driven by healthcare needs, technological innovations, and expanding geographical reach. Companies should focus on regulatory compliance, sustainable packaging, and converging digital technologies to capture market opportunities effectively. Strategic investments in emerging markets and product differentiation will be pivotal in maintaining competitive advantage.


Key Takeaways

  • The global saline solution market will grow at a CAGR of approximately 6-8%, reaching USD 3 billion by 2027.
  • North America dominates, but Asia-Pacific's rapid healthcare expansion presents significant growth opportunities.
  • Innovation in sustainable packaging and digital infusion technology are critical trends influencing market evolution.
  • Regulatory compliance and cost management remain barrier factors; strategic partnerships can facilitate market entry.
  • Sustainable and customizable solutions will define future competitive differentiation.

FAQs

1. What is driving the demand for sodium chloride 5% solutions?
Medical necessity across hospitals, outpatient clinics, emergency care, and home health services, coupled with rising chronic diseases and improved healthcare infrastructure, primarily drive demand.

2. How are environmental concerns affecting this market?
Pressure to reduce plastic waste prompts manufacturers to explore biodegradable and recyclable packaging options, potentially increasing production costs and influencing market offerings.

3. What role does technology play in future market growth?
Digital infusion devices and IoT-enabled monitoring systems enhance safety and efficiency, creating avenues for premium products and expanding market share.

4. Which regions offer the most growth opportunities?
While North America remains dominant, Asia-Pacific, especially China and India, presents high-growth potential due to expanding healthcare access and infrastructure investments.

5. How do regulatory standards impact market dynamics?
Strict regulatory compliance ensures safety and quality but can pose barriers for new entrants, requiring significant investment in manufacturing and validation processes.


Sources:

[1] Market Research Future. "Saline Solution Market Insights." 2022.
[2] Grand View Research. "Global Sterile Saline Solutions Market Analysis." 2023.
[3] World Health Organization. "Global Health Infrastructure Developments." 2022.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.